Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Mülheim an der Ruhr

4 clinical trials in Mülheim an der Ruhr, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Mülheim an der Ruhr at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Mülheim an der Ruhr

Open in trial search

Hormone receptor positive breast cancer+1

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Bladder transitional cell carcinoma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Mülheim an der Ruhr

What the registry says about research in the country

01 Oncology - Urological Cancer

Clinical research focusing on non-muscle invasive bladder cancer treatment, exploring innovative combination therapies. The studies evaluate the effectiveness of combining immunotherapy with standard treatments to improve patient outcomes.

  • Bladder Cancer Therapeutics
  • Immunotherapy Combinations
  • Disease-Free Survival Assessment

Researchers are investigating novel approaches to enhance traditional bladder cancer treatments.

02 Breast Cancer Research

Comprehensive studies targeting both early-stage breast cancer and triple-negative breast cancer. The research encompasses various treatment approaches, including neoadjuvant chemotherapy and targeted therapies.

  • Triple-Negative Breast Cancer
  • Neoadjuvant Treatments
  • Genetic Mutation-Based Therapies

Innovative treatment protocols are being evaluated to improve survival rates and treatment outcomes.

03 Lymphoma Studies

Groundbreaking research in advanced Hodgkin Lymphoma treatment, comparing different therapeutic regimens. The studies focus on reducing treatment toxicity while maintaining therapeutic efficacy.

  • Advanced Stage Treatment
  • Reduced Toxicity Protocols
  • Progression-Free Survival

These trials aim to optimize treatment protocols while minimizing side effects for lymphoma patients.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.